Overview
Global Blood Flow Measurement Devices Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Blood flow measurement devices are designed to access and quantify blood flow within the human body. These devices play a crucial role in various medical specialties including cardiology, vascular surgery, and neurology.
Blood flow meters are used to monitor the blood flow in various blood vessels and to measure cardiac output. Ultrasound doppler, transit-time flow meters, electromagnetic blood flowmeters, and plethysmography chamber flow meters are the commonly used blood flow measurement devices.

Market Dynamics
Increasing product launches
The increasing number of product launches for foot blood flow measurement devices acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new blood flow measurement devices.
For instance, in June 2023, Stat Health launched an in-ear wearable that measures blood flow. It is designed wearable to help understand symptoms like dizziness, brain fog, headaches, fainting, and fatigue.
Additionally, in April 2021, NovaSignal Corp. launched the NovaGuide 2 Intelligent Ultrasound which autonomously measures the blood flow to identify brain illnesses and diseases.
Furthermore, the global blood flow measurement market is driven by various factors like the rising prevalence of cardiovascular diseases, technological advancements, and a rise in demand for blood flow measurement devices are expected to drive the market in the forecast period.
Stringent regulatory approvals
Stringent regulatory approvals for blood flow measurement devices can hamper the market growth as they involve rigorous testing and evaluation of the device to ensure specific standards for accuracy, reliability, and safety.

Segment Analysis
The global blood flow measurement market is segmented based on device type, application, end users and region.
Ultrasound devices accounted for approximately 38.9% of the market share
Doppler ultrasound is a noninvasive test that can be used to estimate the blood flow through the blood vessels by bouncing high-frequency sound waves. Ultrasound devices are expected to hold the largest market share over the period forecast owing to increasing new standard device launches and technological advancements.
For instance, in February 2022, Philips expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities for real-time blood flow on its handheld point-of-care ultrasound called Lumify.
Additionally, in August 2021, Trivitron launched SonoRad V60 Ultrasound. The device is equipped with innovative color flow technology that improves blood flow measurement and visualization and offers a 3D-like flow impression.

Geographical Analysis
North America is expected to hold a significant position in the global blood flow measurement devices market share
The global blood flow measurement devices market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising prevalence of cardiovascular disorders, and product launches, this trend is anticipated to continue throughout the forecast period.
For instance, according to the Centers for Disease Control and Prevention 2023 report, in the United States, heart disease is the top cause of death for both men and women. In the US, an estimated 805,000 people suffer a heart attack annually. Hence, the requirement for blood flow measurement devices increases due to the rising prevalence of cardiovascular diseases.
Additionally, in April 2023, GE HealthCare launched its next-generation intraoperative ultrasound called bkActiv system. It features a sensitive color Doppler to visualize and measure the speed and direction of blood flow during complex surgical procedures.

COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global blood flow measurement devices market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the blood flow measurement devices market is expected to be moderately affected over the forecast period.

Competitive Landscape
The major global players in the market include Cook Medical Inc., Medistim ASA, Transonic Systems, Inc., Deltex Medical Group PLC, Biopac Systems Inc., ATYS Medical, Perimed AB, ADInstruments, Getinge AB, Compumedics Limited among others.
Key Developments

  • In September 2023, Us2.ai partnered with Academic Medical Center to collaborate on AI-enabled echocardiography software. Us2.ai software automated measurements include 2-dimensional spectral Doppler and tissue Doppler.


Why Purchase the Report?

  • To visualize the global blood flow measurement devices market segmentation based on device type, application, end users and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of blood flow measurement devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.


The global blood flow measurement devices market report would provide approximately 61 tables, 58 figures, and 185 Pages.
Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies